Infection with an Extended-Spectrum β-Lactamase-Producing Strain of Serratia marcescens following Tongue Reconstruction
Open Access
- 1 May 2003
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 41 (5) , 2233-2234
- https://doi.org/10.1128/jcm.41.5.2233-2234.2003
Abstract
We report a case of postsurgical wound infection of polymicrobial etiology caused by Serratia marcescens and Pseudomonas aeruginosa following the use of a radial forearm free flap for oncological tongue reconstruction. S. marcescens was a producer of SHV-12 extended-spectrum β-lactamase (ESBL). This is the first report from India of this ESBL. S. marcescens and P. aeruginosa were resistant to the empirical perioperative antibiotics administered. Delay in the recognition of the type of infection and in the institution of appropriate therapy resulted in total loss of the free flap.Keywords
This publication has 11 references indexed in Scilit:
- Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital.2002
- Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240→GlyAntimicrobial Agents and Chemotherapy, 2001
- Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1FEMS Microbiology Letters, 2001
- An outbreak of extended-spectrum, beta-lactamase-producing Salmonella senftenberg in a burns ward.1998
- An outbreak of extended-spectrum, β-lactamase-producing Salmonella senftenberg in a burns wardJournal of Hospital Infection, 1998
- Antimicrobial Resistance with Focus on β-Lactam Resistance in Gram-Negative BacilliThe American Journal of Medicine, 1997
- Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12Antimicrobial Agents and Chemotherapy, 1997
- Microvascular Free Flaps in Head and Neck Reconstruction: Report of 200 Cases and Review of ComplicationsJAMA Otolaryngology–Head & Neck Surgery, 1994
- Prophylactic Antibiotics for Head and Neck Surgery With Flap ReconstructionJAMA Otolaryngology–Head & Neck Surgery, 1992
- An Assessment of the Need for Gram-Negative Bacterial Coverage in Antibiotic Prophylaxis for Oncological Head and Neck SurgeryThe Journal of Infectious Diseases, 1987